ASX's Undervalued Small Caps With Insider Action For December 2024

As the Australian market experiences a potential Santa Rally, with the ASX 200 closing up by 1% at 8,200 and all sectors ending in green, investor sentiment appears optimistic heading into the holiday season. In this environment of broad market gains and sectoral strength, identifying small-cap stocks that are perceived as undervalued can be particularly appealing for investors seeking opportunities amidst insider activity.

Top 10 Undervalued Small Caps With Insider Buying In Australia

Name	PE	PS	Discount to Fair Value	Value Rating
Infomedia	42.1x	3.8x	35.63%	★★★★★★
Collins Foods	15.5x	0.6x	13.08%	★★★★★☆
Dicker Data	19.1x	0.7x	-59.74%	★★★★☆☆
Abacus Group	NA	5.4x	25.17%	★★★★☆☆
Autosports Group	5.8x	0.1x	-52.01%	★★★★☆☆
Healius	NA	0.6x	11.12%	★★★★☆☆
SHAPE Australia	14.9x	0.3x	29.17%	★★★☆☆☆
Coventry Group	217.2x	0.4x	-11.47%	★★★☆☆☆
Corporate Travel Management	22.3x	2.6x	45.42%	★★★☆☆☆
Cromwell Property Group	NA	4.5x	-15.53%	★★★☆☆☆

Click here to see the full list of 24 stocks from our Undervalued ASX Small Caps With Insider Buying screener.

Let's explore several standout options from the results in the screener.

Amotiv (ASX:AOV)

Simply Wall St Value Rating: ★★★★★★

Overview: Amotiv specializes in the production and distribution of automotive components, including powertrain and undercar systems, lighting power and electrical products, as well as 4WD accessories and trailering solutions, with a market cap of A$1.23 billion.

Operations: Amotiv generates revenue primarily from three segments: Powertrain & Undercar, Lighting Power & Electrical, and 4WD Accessories & Trailering. The company's gross profit margin has fluctuated over time, with a notable increase to 57.13% in December 2016 before stabilizing around the mid-40s range in subsequent years. Operating expenses are significant and include costs such as sales and marketing, research and development, and general administrative expenses.

PE: 14.9x

Amotiv, a small Australian company, recently announced a share repurchase program to buy back up to 7 million shares by October 2025. This move could signal insider confidence in the company's prospects. The firm also raised A$5.1 million through a private placement at A$10.25 per share, involving Argo Investments Limited. With earnings projected to grow annually by 8%, Amotiv faces higher risk due to reliance on external borrowing for funding but remains poised for potential growth under new CFO Aaron Canning's leadership.

• Unlock comprehensive insights into our analysis of Amotiv stock in this valuation report.

• Examine Amotiv's past performance report to understand how it has performed in the past.

Dicker Data (ASX:DDR)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Dicker Data is a wholesale distributor specializing in computer peripherals, with operations focused on providing technology solutions in Australia and a market capitalization of A$1.79 billion.

Operations: The company generates revenue primarily from wholesale computer peripherals, with recent quarterly revenues reaching A$2.24 billion. Its gross profit margin has shown an upward trend, reaching 14.54% in the latest period. Operating expenses are a significant component of costs, consistently comprising over A$190 million per quarter recently.

PE: 19.1x

Dicker Data, a key player in Australia's tech distribution, recently affirmed a fully franked dividend of A$0.11 per share for the quarter ending September 2024. Despite being reliant on external borrowing, there's insider confidence with recent purchases indicating belief in its potential. Earnings are projected to grow at 9% annually, suggesting solid prospects for this small company amid financial challenges. Such dynamics highlight its positioning as an attractive opportunity within the Australian market landscape.

• Take a closer look at Dicker Data's potential here in our valuation report.

• Learn about Dicker Data's historical performance.

HealthCo Healthcare and Wellness REIT (ASX:HCW)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: HealthCo Healthcare and Wellness REIT is a real estate investment trust focusing on healthcare and wellness properties, with a market cap of A$0.81 billion.

Operations: HCW generates revenue primarily from its operations, with a notable increase in gross profit margin to 74.58% by the end of 2024. The company incurs costs mainly through cost of goods sold and general & administrative expenses, which have shown variability over recent periods.

PE: 81.3x

HealthCo Healthcare and Wellness REIT shows potential for investors seeking undervalued opportunities within Australia's smaller companies. Despite a dip in profit margin from 42.3% to 9.6%, earnings are projected to climb by 39% annually, suggesting room for growth. The company declared a quarterly dividend of A$0.021, payable February 2025, indicating stable cash flow management despite reliance on external borrowing for funding. Insider confidence is evident with recent share purchases, hinting at optimism about future prospects in the healthcare sector.

• Delve into the full analysis valuation report here for a deeper understanding of HealthCo Healthcare and Wellness REIT.

• Understand HealthCo Healthcare and Wellness REIT's track record by examining our Past report.

Next Steps

• Explore the 24 names from our Undervalued ASX Small Caps With Insider Buying screener here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com